↓ Skip to main content

Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges

Overview of attention for article published in Current Hematologic Malignancy Reports, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#17 of 449)
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users
patent
5 patents

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
225 Mendeley
Title
Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges
Published in
Current Hematologic Malignancy Reports, June 2019
DOI 10.1007/s11899-019-00528-6
Pubmed ID
Authors

Alexandros Nianias, Maria Themeli

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 225 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 50 22%
Researcher 46 20%
Student > Bachelor 30 13%
Student > Master 18 8%
Other 10 4%
Other 18 8%
Unknown 53 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 57 25%
Immunology and Microbiology 31 14%
Agricultural and Biological Sciences 18 8%
Engineering 18 8%
Medicine and Dentistry 13 6%
Other 24 11%
Unknown 64 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#1,795,950
of 25,734,859 outputs
Outputs from Current Hematologic Malignancy Reports
#17
of 449 outputs
Outputs of similar age
#37,556
of 367,094 outputs
Outputs of similar age from Current Hematologic Malignancy Reports
#1
of 19 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 449 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,094 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.